Global Vascular Closure Devices (VCDS) Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.
Vascular Closure Devices were introduced in the early 1990s in an effort to reduce the time to hemostasis, enable early ambulation and improve patient comfort. Initially, devices focused on technologies involving a suture or a collagen plug. These technologies are effective at closing the hole; however, they often leave an intravascular component in the artery, which can cause complications. In addition, these technologies failed to accurately address patient pain. More recent methods to close the hole involve the use of novel materials that dissolve over a short period of time, such as polyethylene glycol found in the Mynx vascular closure device. These technologies incorporate a more gentle deployment of the material to the outside of the artery and avoid the use of intravascular components, leaving nothing behind in the artery and consequently improving patient comfort.
Generally, there are two types of vascular closure devices: active and passive, in this report, vascular closure devices refer to active vascular closure devices.
Global Vascular Closure Devices (VCDS) key players include Abbott Laboratories, St. Jude Medical, Cardinal Health, etc.

Market Analysis and Insights: Global Vascular Closure Devices (VCDS) Market
In 2020, the global Vascular Closure Devices (VCDS) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Vascular Closure Devices (VCDS) Scope and Market Size
The global Vascular Closure Devices (VCDS) market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Vascular Closure Devices (VCDS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
5F-6F
5F-21F

Segment by Application
Angiography Surgery
Interventional Procedures

By Company
Abbott Laboratories
Abbott
Cardinal Health
Morrris Innovative

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE